Co-Diagnostics (STU:C97) Days Payable : 681.21 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Co-Diagnostics Days Payable?

Co-Diagnostics's average Accounts Payable for the three months ended in Mar. 2024 was €1.61 Mil. Co-Diagnostics's Cost of Goods Sold for the three months ended in Mar. 2024 was €0.22 Mil. Hence, Co-Diagnostics's Days Payable for the three months ended in Mar. 2024 was 681.21.

The historical rank and industry rank for Co-Diagnostics's Days Payable or its related term are showing as below:

STU:C97' s Days Payable Range Over the Past 10 Years
Min: 6.64 Med: 106.14 Max: 26645
Current: 139.14

During the past 9 years, Co-Diagnostics's highest Days Payable was 26645.00. The lowest was 6.64. And the median was 106.14.

STU:C97's Days Payable is ranked better than
75% of 784 companies
in the Medical Devices & Instruments industry
Industry Median: 72.505 vs STU:C97: 139.14

Co-Diagnostics's Days Payable increased from Mar. 2023 (162.85) to Mar. 2024 (681.21). It may suggest that Co-Diagnostics delayed paying its suppliers.

Co-Diagnostics Days Payable Historical Data

The historical data trend for Co-Diagnostics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Co-Diagnostics Days Payable Chart

Co-Diagnostics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

245.74

6.65

18.35

50.69

107.37

Co-Diagnostics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															162.85	253.41	552.63	45.02	681.21

Competitive Comparison of Co-Diagnostics's Days Payable

For the Medical Devices subindustry, Co-Diagnostics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Co-Diagnostics's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Co-Diagnostics's Days Payable distribution charts can be found below:

* The bar in red indicates where Co-Diagnostics's Days Payable falls into.

Co-Diagnostics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Co-Diagnostics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.899	+	1.359)	/	2 )	/	3.838	*	365
=	1.129					/	3.838	*	365
=	107.37

Co-Diagnostics's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (1.359	+	1.866)	/	2 )	/	0.216	*	365 / 4
=	1.6125					/	0.216	*	365 / 4
=	681.21

Co-Diagnostics Days Payable Related Terms

Thank you for viewing the detailed overview of Co-Diagnostics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Co-Diagnostics (STU:C97) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Co-Diagnostics Inc (STU:C97) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

CODX:USA 0A50:UK

Address

2401 South Foothill Drive, Salt Lake City, UT, USA, 84109

Website

https://www.codiagnostics.com

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

Co-Diagnostics (STU:C97) Headlines

No Headlines